Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Climate-Resistant Oilseed Crop Plant Developed

An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate. . . . → Read More: Climate-Resistant Oilseed Crop Plant Developed

Regeneron to Sequence 500K UK Biobank Genomes

A biotech company and health database center are partnering with drug maker GlaxoSmithKline to produce genomic data on 500,000 individuals for drug discovery. . . . → Read More: Regeneron to Sequence 500K UK Biobank Genomes

Inhaled Drug Shown Feasible for Postpartum Bleeding

Results from a clinical trial show a dry-powder inhaled form of the drug oxytocin works in the body much like the injected form, given to prevent postpartum hemorrhage, excessive bleeding in some women after childbirth. . . . → Read More: Inhaled Drug Shown Feasible for Postpartum Bleeding

Heart Assoc, Amazon Partner on Precision Medicine Data

American Heart Association and Amazon Web Services are collecting data from researchers to advance precision medicine in cardiovascular diseases and stroke. . . . → Read More: Heart Assoc, Amazon Partner on Precision Medicine Data

Allergan to Option Gene Editing for Eye Diseases

International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard. . . . → Read More: Allergan to Option Gene Editing for Eye Diseases

Messenger RNA Engineered to Produce Antibodies

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies

Biotech Companies to Discover Ebola, Zika Vaccines

Two biotechnology companies are collaborating to discover new vaccines protecting against Ebola and Zika viruses that present global threats to public health. . . . → Read More: Biotech Companies to Discover Ebola, Zika Vaccines

Genome Editing Builds Viral Disease Resistance in Pigs

Veterinary researchers used Crispr-Cas9, an emerging genome editing technique, to produce pigs with cells resistant to a common viral disease affecting commercial herds. . . . → Read More: Genome Editing Builds Viral Disease Resistance in Pigs

Skin Health Data Collected by App Offered for Research

A smartphone app collecting images and data about moles on the skin of volunteers is now available to researchers for studies of cancer and other disorders. . . . → Read More: Skin Health Data Collected by App Offered for Research

Ford Investing $1B in Artificial Intelligence Start-Up

Ford Motor Company is investing $1 billion in a start-up enterprise that applies artificial intelligence to the operation and management of autonomous vehicles. . . . → Read More: Ford Investing $1B in Artificial Intelligence Start-Up